Introvale (levonorgestrel and ethinyl estradiol) tablets, USP, 0.15 mg/0.03 mg, packaged in 91 da...

FDA Drug Recall #D-854-2013 — Class III — August 7, 2013

Recall Summary

Recall Number D-854-2013
Classification Class III — Low risk
Date Initiated August 7, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Sandoz Incorporated
Location Broomfield, CO
Product Type Drugs
Quantity 8, 681 unit cartons

Product Description

Introvale (levonorgestrel and ethinyl estradiol) tablets, USP, 0.15 mg/0.03 mg, packaged in 91 day regimen per unit carton, 3 Unit Cartons x 91 tablets per box, Rx only, Manufactured by Laboratorios Leon Farma S.A., Spain for Sandoz Inc., Princeton, NJ 08540, NDC 0781-5584-36

Reason for Recall

Contraceptive tablets out of sequence: Contraceptive tablets out of sequence: Introvale (levonorgestrel and ethinyl estradiol tablets USP 0.15mg/0.03mg) is voluntarily being recalled due to inactive placebo tablets incorrectly placed in Week 9, and active tablets placed in Week 13 on the blister card

Distribution Pattern

Nationwide

Lot / Code Information

Lots: LF01643C, LF01644C, Exp 7/14

Other Recalls from Sandoz Incorporated

Recall # Classification Product Date
D-0631-2018 Class III Triamterene and Hydrochlorothiazide Tablets, US... Apr 6, 2018
D-0943-2017 Class III Amitriptyline HCl Tablets, USP 25 mg, Packaged ... Jun 16, 2017
D-0236-2017 Class II Nadolol Tablets, USP, 40mg, packaged in 1000-co... Dec 22, 2016
D-0291-2015 Class III Fluoxetine Capsules USP, 20 mg, 100 count bottl... Dec 5, 2014
D-1509-2014 Class II Alprazolam Tablets, USP, 0.25mg, Rx only, 1000 ... Jul 25, 2014

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.